In vitro characterization of human plasma fraction factor VIIi concentrate
Uteg, K.H.; Tausenfreund, K.; Schössler, W.
Die Pharmazie 40(4): 270
1985
ISSN/ISBN: 0031-7144 PMID: 3925469 Document Number: 257508
Document emailed within 1 workday
Related Documents
Takahashi, I.; Furuta, M.; Mizuno, S.; Takamatsu, J.; Kamiya, T. 1993: Effect of substrate and diluent for factor VIIi activity in highly purified factor VIIi concentrate and patient plasma infused factor VIIi concentrate Rinsho Byori. Japanese Journal of Clinical Pathology 41(7): 825-830Stephan, W.; Prince, A.M.; Kotitschke, R. 1983: Factor VIIi concentrate from cold sterilized human plasma Developments in Biological Standardization 54: 491-495
Teitel, J.M.; Lau, H.K.; Garvey, M.B. 2002: Discrepancies in measured factor VIIi activity in patients treated with factor VIIi concentrate of human or porcine origin Thrombosis and Haemostasis 88(1): 159-160
Brettler, D.B.; Forsberg, A.D.; Levine, P.H.; Aledort, L.M.; Hilgartner, M.W.; Kasper, C.K.; Lusher, J.M.; McMillan, C.; Roberts, H. 1989: The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience Archives of Internal Medicine 149(6): 1381-1385
Allersma, D.P.; Smid, W.M.; van der Does, J.A.; van der Meer, J.; Briët, E. 1996: Effects of chronic factor VIII substitution on immune parameters in HIV seronegative haemophiliacs: a comparison between cryoprecipitate and factor VIII concentrate Thrombosis and Haemostasis 75(2): 261-266
Arrighi, S.; Rossi, R.; Borri, M.G.; Lesnikov, V.; Lesnikova, M.; Franco, E.; Divizia, M.; De Santis, M.E.; Bucci, E. 1995: "In vitro" and in animal model studies on a double virus-inactivated factor VIII concentrate Thrombosis and Haemostasis 74(3): 868-873
Simonetti, C.; Casillas, G.; Farías, C.; De los Santos, J.C. 1981: A new human factor VIIi concentrate. Preparation and clinical use Medicina 41 Suppl: 249-252
Kessler, C.M.; Ludlam, C.A. 1993: The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group Seminars in Hematology 30(2 Suppl. 1): 22-27
Muntean, W. 1984: Purified complex of factor VIII coagulant moiety and phospholipid: high factor VIII coagulant activity in factor VIII inhibitor plasma Wiener Klinische Wochenschrift 96(22): 829-832
Yoshioka, A.; Shima, M.; Nishino, M.; Yoshikawa, N.; Fukui, H. 1987: In vitro characterization of various factor VIII concentrates Arzneimittel-Forschung 37(7): 753-756
Andes, W.A. 1983: Factor VIIi concentrate--hepatitis JAMA 249(17): 2331
Allain, J.P.; Steinbuch, M.; Meunier, L.; Muller, J.Y.; Soulier, J.P. 1976: Substitutive treatment of hemopjolia a using a new factor VIIi concentrate La Nouvelle Presse Medicale 5(16): 1047-1050
Mahasandana, C.; Suvatte, V.; Püng-amritt, P.; Tuchinda, S. 1979: Von Willebrand's disease: studies of platelet functions, factor VIII procoagulant activity (F VIII C) and factor VIII-related antigen (F VIII RAg) in three families Southeast Asian Journal of Tropical Medicine and Public Health 10(2): 243-247
Lane, J.L.; Ekert, H.; Vafiadis, A. 1979: Affinity chromatography of human factor VIII using human and rabbit antibodies to Factor VIII Thrombosis and Haemostasis 42(4): 1306-1315
Brown, J.E.; Carton, C.L.; Hougie, C. 1981: The effect of naturally occurring antibodies to factor VIIi on an immunoradiometric assay for factor VIIi coagulant antigen. Observation on a cross-reacting material-positive (CRM+) hemophiliac with a factor VIIi inhibit Journal of Laboratory and Clinical Medicine 97(1): 65-71
Kunst, V.A.; Nováková, I.R.; Haanen, C. 1989: Cryoprecipitate should have preference over factor VIII concentrate in the treatment of patients with hemophilia A Nederlands Tijdschrift Voor Geneeskunde 133(23): 1163-1166
Kolho, E.; Ebeling, F.; Rasi, V. 1992: Risk of HCV infection in haemophiliacs treated with a dry-heated factor VIII concentrate Thrombosis and Haemostasis 67(6): 728
Laurian, Y.; Dussaix, E.; Parquet, A.; Chalvon-Demersay, A.; d'Oiron, R.; Tchernia, G. 1994: Transmission of human parvovirus B19 by plasma derived factor VIIi concentrates Nouvelle Revue Francaise d'Hematologie 36(6): 449-453
Van Vliet, H.H.D.M.; Kappers-Klunne, M.C.; Leebeek, F.W.G.; Michiels, J.J. 2008: PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2 Thrombosis and Haemostasis 100(3): 462-468
Lostický, C.; Bednarík, T.; Cajthamlová, H. 1982: Chromatographic characterization of the low molecular weight immunosuppressive component of the alpha globulin fraction in human plasma Ceskoslovenska Farmacie 31(5): 171-173